Large US study of HIV vaccine is halted because of lack of efficacyBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2734 (Published 29 April 2013) Cite this as: BMJ 2013;346:f2734
- Michael McCarthy
The trial of an HIV vaccine involving more than 2000 volunteers in 19 cities in the United States is being abandoned after independent inspectors found that it did not prevent HIV infection or reduce viral load among those who became infected with the virus.
The HVTN 505 study began in 2009 to assess the effectiveness of an …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial